FLG and Alzheimer disease: Skin barrier dysfunction in AD occurs due to decreased levels of total ceramides and changes in its composition (changes in ceramide chain length, free fatty acids, and esterified fatty acids), which disrupts epidermal lipid organization; decreased expression of other epidermal differentiation-related molecules such as filaggrin (FLG), loricrin, involucrin production.